These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21052689)

  • 1. Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects.
    Shiga T; Tanaka T; Irie S; Hagiwara N; Kasanuki H
    Heart Vessels; 2011 May; 26(3):274-81. PubMed ID: 21052689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic properties of a single intravenous dose of ibutilide fumarate: a phase I, randomized, open-label, increasing-dose study in healthy Chinese men.
    Li Y; Tian L; Huang Y; Hua L
    Clin Ther; 2007 Sep; 29(9):1957-66. PubMed ID: 18035195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population.
    Kashima A; Funahashi M; Fukumoto K; Komamura K; Kamakura S; Kitakaze M; Ueno K
    Biol Pharm Bull; 2005 Oct; 28(10):1934-8. PubMed ID: 16204949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor.
    Teng R; Sarich TC; Eriksson UG; Hamer JE; Gillette S; Schützer KM; Carlson GF; Kowey PR
    J Clin Pharmacol; 2004 Sep; 44(9):1063-71. PubMed ID: 15317834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data.
    Lu JT; Cai Y; Chen F; Jia WW; Hu ZY; Zhao YS
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):689-703. PubMed ID: 26254911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of intravenous amiodarone in subjects with normal and impaired renal function.
    Ujhelyi MR; Klamerus KJ; Vadiei K; O'Rangers E; Izard M; Neefe DL; Zimmerman JJ; Chow MS
    J Clin Pharmacol; 1996 Feb; 36(2):122-30. PubMed ID: 8852388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic inhibition of amiodarone metabolism induced by grapefruit juice.
    Libersa CC; Brique SA; Motte KB; Caron JF; Guédon-Moreau LM; Humbert L; Vincent A; Devos P; Lhermitte MA
    Br J Clin Pharmacol; 2000 Apr; 49(4):373-8. PubMed ID: 10759694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability study with two amiodarone tablet formulations administered with and without food in healthy subjects.
    dos Santos Filho HO; Ilha JO; Silva LC; Borges A; Mendes GD; De Nucci G
    Arzneimittelforschung; 2007; 57(9):582-90. PubMed ID: 17966757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amiodarone and desethylamiodarone concentrations following nasogastric versus oral administration.
    Kotake T; Takada M; Goto T; Komamura K; Kamakura S; Morishita H
    J Clin Pharm Ther; 2006 Jun; 31(3):237-43. PubMed ID: 16789989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects.
    Kim BH; Kim JR; Lim KS; Kim JW; Kim KP; Hong JH; Jang IJ; Shin SG; Yu KS; Tanaka T
    Clin Ther; 2009 Mar; 31(3):609-18. PubMed ID: 19393851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence of 2 intravenous amiodarone formulations in healthy participants.
    Cushing DJ; Adams MP; Cooper WD; Kowey PR; Lipicky RJ
    J Clin Pharmacol; 2009 Apr; 49(4):407-15. PubMed ID: 19246726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative bioavailability of a premixed, ready-to-use formulation of intravenous amiodarone with traditional admixture in healthy subjects.
    Cushing DJ; Adams MP; Cooper WD; Agha B; Souney PF
    J Clin Pharmacol; 2012 Feb; 52(2):214-21. PubMed ID: 21257800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous amiodarone in patients with impaired left ventricular function.
    Vadiei K; O'Rangers EA; Klamerus KJ; Kluger J; Kazierad DJ; Leese PT; Chow MS; Zimmerman JJ
    J Clin Pharmacol; 1996 Aug; 36(8):720-7. PubMed ID: 8877676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based pharmacokinetic modeling to predict drug-drug interactions involving inhibitory metabolite: a case study of amiodarone.
    Chen Y; Mao J; Hop CE
    Drug Metab Dispos; 2015 Feb; 43(2):182-9. PubMed ID: 25324279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
    Shayeganpour A; Hamdy DA; Brocks DR
    Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone concentration in human myocardium after rapid intravenous administration.
    Anastasiou-Nana MI; Nanas JN; Alexopoulos G; Karli JN; Margari ZJ; Agapitos E; Patsi EN; Stamatelopoulos SF
    Cardiovasc Drugs Ther; 1999 May; 13(3):265-70. PubMed ID: 10439890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of orlistat, a lipase inhibitor, on the pharmacokinetics of three highly lipophilic drugs (amiodarone, fluoxetine, and simvastatin) in healthy volunteers.
    Zhi J; Moore R; Kanitra L; Mulligan TE
    J Clin Pharmacol; 2003 Apr; 43(4):428-35. PubMed ID: 12723464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of epicardial application of drug-releasing hydrogels to prevent postoperative atrial fibrillation.
    Wang W; Mei YQ; Yuan XH; Feng XD
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):80-5. PubMed ID: 26254755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.